Tesaro, Inc.

Tesaro, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

TESARO is an oncology-focused business within GlaxoSmithKline (GSK) with a clear mission that drives all of our actions. We are dedicated to improving the oncology experience and have a passionate commitment to unconditional care, which puts science for patients first. At TESARO, we bring together working lives and human lives, inspiring future leaders, and building lasting careers. It’s a commitment we make to each member of our team. We care for you, so you can unconditionally care for people living with cancer.

Company Details

Employees
55
Address
1000 Winter St, Waltham,massachusetts 02451,united States
Phone
339.970.0900
Email
co****@****bio.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Waltham, Massachusetts
Looking for a particular Tesaro, Inc. employee's phone or email?

Tesaro, Inc. Questions

News

U.S. Food and Drug Administration accepts GSK’s application for ZEJULA (niraparib) in late stage ovarian cancer with priority review - GSK

U.S. Food and Drug Administration accepts GSK’s application for ZEJULA (niraparib) in late stage ovarian cancer with priority review GSK

Rolapitant Proves Effective for the Prevention of Chemotherapy-Induced Nausea and Vomiting - Cancer Therapy Advisor

Rolapitant Proves Effective for the Prevention of Chemotherapy-Induced Nausea and Vomiting Cancer Therapy Advisor

Tesaro Announces U.S. Fda Approval Of Zejula™ (Niraparib) Ovarian Cancer - MultiVu

Tesaro Announces U.S. Fda Approval Of Zejula™ (Niraparib) Ovarian Cancer MultiVu

TESARO Announces Availability of VARUBI® (rolapitant) IV - GlobeNewswire

TESARO Announces Availability of VARUBI® (rolapitant) IV GlobeNewswire

TESARO ANNOUNCES THE LAUNCH OF VARUBI™ (ROLAPITANT) IN THE UNITED STATES - MultiVu

TESARO ANNOUNCES THE LAUNCH OF VARUBI™ (ROLAPITANT) IN THE UNITED STATES MultiVu

ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial - GlobeNewswire

ENGOT and TESARO Partnership Generates Positive Data From ENGOT-OV16/NOVA Phase 3 Trial GlobeNewswire

TESARO Announces U.S. FDA Approval of VARUBI® IV for - GlobeNewswire

TESARO Announces U.S. FDA Approval of VARUBI® IV for GlobeNewswire

Top Tesaro, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant